Abiopharma

Clinical trial NCT04748419 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2026-03-01 → 2025-09-26 3. primary completion date: 2026-03-01 → 2025-09-26

Clinical trial NCT05017012 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. enrollment: 72 → 142 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04296695 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-12-31 → 2025-06-06 3. enrollment: 250 → 202 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07359820: start date: 2026-05-01 → 2026-06-04.

Clinical trial NCT07164443 updates: 1. completion date: 2028-05-30 → 2027-12-29 2. primary completion date: 2028-05-30 → 2027-12-29

Clinical trial NCT07217587: completion date: 2028-12-11 → 2029-07-31.

Clinical trial NCT04133636: enrollment: 210 → 208 participants.

Clinical trial NCT07104032: start date: 2026-05-01 → 2026-06-01.

Clinical trial NCT04997902 updates: 1. completion date: 2025-07-30 → 2025-08-29 2. primary completion date: 2025-07-30 → 2025-08-29

Clinical trial NCT07165678 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-09-30 → 2026-04-16 3. completion date: 2028-11-30 → 2029-07-31 4. primary completion date: 2027-09-30 → 2029-07-31